Group 1 - Truist raised the price target on Nuvation Bio (NUVB) to $13 from $11 while maintaining a Buy rating on the shares [1] - The firm believes the Ibtrozi franchise has demonstrated strong initial uptake, positioning it as the preferred ROS1 agent compared to competitors [1] - The analysis highlights that the uptake of Ibtrozi has been stronger than anticipated despite facing seasonal headwinds [1]

Group 1 - Jefferies has lowered the price target on Chord Energy (CHRD) to $99 from $101 while maintaining a Hold rating on the shares [1] - The firm anticipates an improvement in the company's capital efficiency due to a softening service environment [1] - This improvement is expected to drive capital expenditures (capex) to exceed consensus estimates in 2026 [1]

Group 1 - Citi analyst John Godyn raised the price target on Allegiant Travel (ALGT) to $109 from $88 while maintaining a Neutral rating on the shares [1] - The firm updated targets in the airlines group as part of a Q4 earnings preview [1] - Citi's business travel barometer has bottomed, indicating a potential recovery in business travel [1] Group 2 - Despite the positive outlook on business travel, the firm expects supermajors to issue "conservative" outlooks for 2026 [1]

Group 1 - Citi raised the price target on American Airlines (AAL) to $21 from $19 while maintaining a Buy rating on the shares [1] - The update on targets in the airlines group is part of a Q4 earnings preview [1] - Citi's business travel barometer has bottomed, indicating a potential recovery in business travel [1] Group 2 - Despite the positive outlook, the firm expects supermajors to issue "conservative" outlooks for 2026 [1]

Group 1 - Citi raised the price target on Southwest Airlines (LUV) to $44 from $38 while maintaining a Neutral rating on the shares [1] - The update on targets in the airlines group is part of a Q4 earnings preview [1] - Citi's business travel barometer has reached its lowest point, indicating a potential recovery in business travel [1] Group 2 - Despite the positive indicators, the firm anticipates that supermajors will provide "conservative" outlooks for 2026 [1]